Actively Recruiting

Phase 1
Age: 20Years - 60Years
All Genders
ID07429448

Comparison of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Patients Undergoing Open Appendectomy

Led by Sardar Umer Rehman · Updated on 2026-02-24

60

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

S

Sardar Umer Rehman

Lead Sponsor

S

Services Institute of Medical Sciences, Pakistan

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are comparing the effects of intraperitoneal bupivacaine instillation versus a placebo as preemptive pain relief in patients undergoing open appendectomy. The study focuses on evaluating pain management outcomes after surgery, specifically looking at postoperative pain within 24 hours. This is a phase 1 trial involving adult patients aged 20 to 60 undergoing emergency open appendectomy. Participants are randomly assigned to receive either 0.25% bupivacaine or 10 ml of normal saline instilled into the peritoneal cavity at the end of the operation. Both groups will have surgery duration noted, and pain relief and analgesic use will be monitored at 2, 6, 12, and 24 hours postoperatively. Rescue medications like ketorolac and nalbuphine will be used if pain scores reach certain levels. All patients will receive intravenous paracetamol as first-line analgesia. Patients are expected to be discharged two days after surgery once diet and pain are manageable, with additional oral pain medications provided if needed. During the study, researchers will closely record analgesic consumption and pain scores using a visual analogue scale. Follow-up will continue according to protocol to monitor ongoing pain and recovery. All information will be collected on a standardized form. The main outcome measured is postoperative pain within the first 24 hours. The trial aims to determine whether bupivacaine instillation offers better pain control compared to placebo during open appendectomy procedures.

CONDITIONS

Brief Title

Comparison Of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Patients Undergoing Open Appendectomy

Who Can Participate

Age: 20Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients presenting to the emergency department undergoing open appendectomy
  • Age between 20 and 60 years
  • Both males and females are eligible
Not Eligible

You will not qualify if you...

  • Patients undergoing interval appendectomy or with perforated appendix confirmed by physical exam and ultrasound
  • Uncontrolled diabetes with blood sugar above 200 mg/dl or hypertension with blood pressure above 140/90
  • History of chronic kidney disease, liver disease, psychiatric illness, or active peptic ulcer disease
  • Alcohol use disorder
  • History of chronic pain or current use of analgesic medications
  • Pregnant females
  • Allergy to bupivacaine or ketorolac
  • Children, adolescents, or patients with mental illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Surgery and Immediate Post-operative Care

Duration - 2 days

Participants undergo open appendectomy during which they receive either intraperitoneal Bupivacaine or normal saline as preemptive analgesia. Surgery duration is noted. Analgesic consumption and pain levels are monitored closely after surgery.

1 surgery visit and multiple assessments at 2, 6, 12, and 24 hours postoperatively

Post-operative Follow-up

Duration - 3 to 4 days

Participants are monitored for pain and recovery after discharge. Oral analgesics are given if pain persists. Follow-up assessments are done as per protocol to record recovery progress and pain management.

1 to 2 follow-up visits after discharge

Trial Site Locations

Total: 1 location

1

Services Institute of Medical Sciences/ Services Hospital Lahore

Lahore, Punjab Province, Pakistan, 54000

Actively Recruiting

Loading map...

Research Team

D

Dr Sardar Umar Rehman, MBBS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Global Prospective Cohort Study on Outcomes of Appendicect...

Appendicitis

Actively Recruiting

7 locations

Using the Fitbit for Early Detection of Infection and Reduct...

Appendectomy

Actively Recruiting

4 locations

Exploring the Impact of Genetic Variations on The Clinical E...

Cholecystectomy

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here